We are live on
!
Find out more
KWMG
King Wealth Management Group Portfolio holdings
AUM
$914M
1-Year Est. Return
24.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.77%
1 Year Est. Return
+24.3%
3 Year Est. Return
+85.96%
5 Year Est. Return
+105%
10 Year Est. Return
+377.86%
AUM
$642M
AUM Growth
+$41.9M
(+7%)
Cap. Flow
+$9.64M
Cap. Flow
% of AUM
1.5%
Top 10 Holdings %
Top 10 Hldgs %
55.92%
Holding
157
New
13
Increased
36
Reduced
77
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$12.5M |
| 2 |
Parker-Hannifin
PH
|
+$5.67M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$1.72M |
| 4 |
Trane Technologies
TT
|
+$1.68M |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$5.25M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$2.11M |
| 3 |
Vanguard Morningstar Value ETF
VTV
|
+$1.53M |
| 4 |
Dollar General
DG
|
+$924K |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$684K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.42% |
| 2 | Healthcare | 9.19% |
| 3 | Financials | 7.76% |
| 4 | Consumer Staples | 4.97% |
| 5 | Consumer Discretionary | 4.83% |
Similar funds
PTC
SI
GIG
SAA
GC
KCM
SC
FFL
King Wealth Management Group's Q3 2024 Portfolio in Review
As of Q3 2024, King Wealth Management Group held 157 positions worth $642M, up 7% from $600M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
King Wealth Management Group's Q3 2024 filing shows 13 new, 36 increased, 77 reduced and 6 closed positions. Its largest new stake was Teva Pharmaceuticals: 98,102 shares worth $1.77M. The largest sale was Johnson & Johnson, an estimated $5.25M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- King Wealth Management Group's largest Q3 2024 buy was Teva Pharmaceuticals: 98,102 shares worth $1.77M.
- King Wealth Management Group added most to Microsoft in Q3 2024, an estimated $12.5M increase.
- King Wealth Management Group's biggest Q3 2024 reduction was Johnson & Johnson, cutting an estimated $5.25M.
- King Wealth Management Group fully exited Novo Nordisk in Q3 2024, selling an estimated $2.11M.
- King Wealth Management Group's ten largest holdings make up 56% of its $642M portfolio in Q3 2024.
- King Wealth Management Group opened 13 new positions and closed 6 in Q3 2024.
- King Wealth Management Group's portfolio value rose 7% quarter-over-quarter to $642M.
Based on King Wealth Management Group's 13F filing for Q3 2024, filed 6 Nov 2024.